Aurobindo Pharma gains 3.5% on buyback plans

Aurobindo Pharma gains 3.5% on buyback plans



Aurobindo Pharma shares ended 3.53% larger on Monday within the wake of the drugmaker on Sunday hinting at an impending buyback. The shares closed at ₹1,373.85 apiece on the BSE. In a submitting, the corporate had introduced that its board would meet on July 18 to think about, amongst others, a proposal for buyback of the totally paid-up fairness shares of the corporate and the issues obligatory and incidental thereto.





Source link